Indefinite Delivery Contract 36E79726D0001
Award Date 1/20/26
Last Date to Order 1/19/27
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
- Hikma Specialty USA Inc. has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule through the Department of Veterans Affairs, Veterans Integrated Service Network 12, for the provision of drugs, pharmaceuticals, and hematology-related products. The contract, awarded on June 1, 2022, carries a ceiling value of $1,250,080.00 and extends through May 31, 2027, with no set-aside designation applied. As a manufacturer of...
- The key products and services being delivered under this federal contract IDV award are pharmaceutical and hematology-related products. The prime contractor, Hikma Pharmaceuticals USA Inc., is a foreign-owned, for-profit pharmaceutical manufacturer that specializes in producing generic injectable and non-injectable pharmaceutical products. Hikma holds two significant federal contract IDVs under this award: a $216 million multiple-award Federal Supply Schedule contract with the Department of...
- Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) holds a single-award Indefinite Delivery Contract valued at $42.9 million with the Defense Logistics Agency Medical Supply Chain, with an award date of July 14, 2020 and completion date of July 14, 2030. This contract vehicle, classified as a manufacture/distributor agreement, establishes an indefinite-quantity framework enabling the Defense Logistics Agency to procure a comprehensive array of pharmaceutical products to...
- The federal contract IDV award is a single-award indefinite delivery contract awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Concordia Pharmaceuticals Inc. for the procurement of Hydroxychloroquine SO4 200mg tablets. The contract has a total ceiling value of $20,293,080.60 and a period of performance from September 23, 2020 to September 22, 2025, with an initial one-year base period and four one-year option periods. The contract aims to provide an...
- The National Acquisition Center awarded a single-award Blanket Purchase Agreement to Nobelpharma America, LLC for the supply of HYFTOR, a pharmaceutical product, to the Department of Veterans Affairs. This BPA, effective from June 22, 2023, through June 21, 2026, carries a ceiling value of $4.5 million and operates under Federal Supply Class 65-IB for pharmaceutical and hematology-related products. As a civilian contract with no set-aside designation, this BPA streamlines the federal procurement...
- The Harvard Drug Group, L.L.C., doing business as Major Pharmaceuticals, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on December 10, 2024, to supply Lurasidone Hydrochloride tablets to federal healthcare systems. The contract carries a ceiling value of $10,056,938.10 and extends through December 9, 2026, with a base year ordering period from December 10, 2024, to December 9, 2025, followed by four one-year option...
- The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029. Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
- This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract has a ceiling value of $40,480,225.15 and a period of performance from February 12, 2022 to February 11, 2023, with four one-year option periods. The contract was awarded to provide an uninterrupted supply of various strengths and package sizes of...
- This federal Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Bryant Ranch Prepack, a for-profit manufacturer of pharmaceutical goods. The single-award, unrestricted contract has a ceiling value of $14,563,769.10 and covers the supply of Hydroxychloroquine SO4 200MG tablets in 100-tablet and 500-tablet packages to support the procurement needs of the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health...